Trial ID or NCT#

NCT00726453

Status

NOT RECRUITING

Purpose

The objective of the study is to assess the safety and effectiveness of the Resolute Zotarolimus-Eluting Coronary Stent System for the treatment of de novo lesions in native coronary arteries with a reference vessel diameter (RVD) of 2.25 mm to 4.2 mm.

Investigator(s)

Alan Yeung, MD

Contact us to find out if this trial is right for you.

CONTACT

Maria Perlas
(650) 723-2094